Cresco Labs (OTCMKTS:CRLBF) Trading Down 1.2% - Should You Sell?

Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report)'s stock price traded down 1.2% during mid-day trading on Friday . The stock traded as low as $0.49 and last traded at $0.50. 268,752 shares were traded during trading, a decline of 56% from the average session volume of 604,768 shares. The stock had previously closed at $0.51.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Canaccord Genuity Group lowered Cresco Labs from a "strong-buy" rating to a "moderate buy" rating in a research report on Tuesday, June 3rd. Cormark upgraded Cresco Labs from a "hold" rating to a "moderate buy" rating in a report on Monday, March 17th. Two research analysts have rated the stock with a hold rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy".

View Our Latest Analysis on Cresco Labs

Cresco Labs Stock Performance

The company has a market capitalization of $246.49 million, a PE ratio of -2.09 and a beta of 1.47. The company has a current ratio of 2.75, a quick ratio of 1.98 and a debt-to-equity ratio of 1.63. The firm's 50-day simple moving average is $0.65 and its 200-day simple moving average is $0.77.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last announced its quarterly earnings results on Friday, May 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.01). The firm had revenue of $165.76 million during the quarter, compared to analysts' expectations of $164.37 million. Cresco Labs had a negative net margin of 11.86% and a negative return on equity of 21.77%. On average, research analysts predict that Cresco Labs Inc. will post -0.2 earnings per share for the current year.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Featured Articles

• Five stocks we like better than Cresco Labs
• 3 Natural Gas Stocks That Offer Great Dividend Yields
• EA Just Caught a Monster Upgrade: Bullish Breakout Ahead?
• 3 Monster Growth Stocks to Buy Now
• 3 Stocks Hitting All-Time Highs With More Room to Run
• Quiet Period Expirations Explained
• QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cresco Labs Right Now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here